相关实验视频

Updated: May 9, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

神经成像相关的领域特定的认知缺陷在肌缩性侧面硬化症

Harold H G Tan¹, Abram D Nitert¹, Kevin van Veenhuijzen¹

¹Department of Neurology, UMC Utrecht Brain Centre, Utrecht University, Utrecht, the Netherlands.

NeuroImage. Clinical

|February 13, 2025

概括

大脑MRI揭示了与认知和行为缺陷相关的肌缩侧面硬化症 (ALS) 中明显的神经退行模式. 这种成像方法可以跟踪ALS患者的疾病进展.

科学领域:

神经科学是一个神经科学.
放射学放射学是一门学科.
神经学神经学

背景情况:

肌缩侧面硬化症 (ALS) 是一种致命的神经退行性疾病.
ALS经常涉及额外运动症状,包括认知和行为变化.
了解大脑变化与这些缺陷之间的关系至关重要.

研究的目的:

研究ALS患者特定认知和行为缺陷之间的相关性.
在脑MRI上识别超运动神经退行症的独特模式.
用MRI来区分与ALS相关的变化与正常的衰老.

主要方法:

多种模式的大脑MRI和爱丁堡认知和行为ALS屏幕 (ECAS) 对293名ALS患者和237名对照进行了测试.
认知得分与灰色和白质MRI参数进行了比较.
来自171名患者的纵向数据评估了随时间的变化;相互作用分析将ALS患者与对照进行了比较.

主要成果:

语言缺陷与灰质神经退行相关 (正面,,,皮层,皮层下).
记忆问题与海马体和中间时缩有关;与白质变化相关的执行功能障碍.
大多数MRI-认知相关性在ALS中比对照中更强;灰质结构随着时间的推移而恶化,但认知分数没有显著下降.

结论:

大脑MRI有效地捕捉到ALS认知和行为缺陷的异质性.
磁力共振成像 (MRI) 作为一个有价值的纵向生物标志物,用于跟踪ALS中超运动神经退行进展.
这种方法有助于理解ALS复杂的神经生物学基础.

关键词:

肌缩性侧面硬化症 (AMLS) 是一种疾病.脑部成像脑部成像认知障碍认知障碍是一种认知障碍.额头时性痴呆症是什么?这就是为什么MRI是MRI.运动神经元疾病运动神经元疾病神经心理学评估神经心理学评估

更多相关视频

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice

Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice

Published on: July 31, 2019

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

Dementia l: Introduction

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...